IRCT20220504054735N1Completed
Magnesium supplement therapy in type2 diabetes
Serum magnesium levels in type 2 diabetic patients and effect of magnesium supplement therapy in glycemic control and insulin resistance of these patients
Tabriz University of Medical SciencesPhase 3Iranian Registry Of Clinical Trial
VerifiedIranian Registry Of Clinical Trial
Study focus
- Disease/Condition
- Type 2 diabetes mellitus
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Tabriz University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 3
- Start date
- Jul 06, 2022
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20220504054735N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20220504054735N1 through Pure Global AI's free database. This Phase 3 trial is sponsored by Tabriz University of Medical Sciences and is currently Completed. The study focuses on Type 2 diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.